Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections

Severe pulmonary infections are a leading cause of death in adults worldwide. Romain Pirracchio, MD, MPH, PhD, of the University of California-San Francisco, joins JAMA Deputy Editor Kristin L. Walter, MD, MS, to discuss Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections. Related Content: Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections